MedPath

Efficacy and safety of Artesunate plus Amodiaquine , Artemether-Lumefantrine and Dihydroartemisinin+Piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children 6 – 59 months in three sentinel sites; Sierra Leone.

Phase 4
Completed
Conditions
Malaria
Registration Number
ACTRN12618000517279
Lead Sponsor
Ministry of Health and Sanitation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
275
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath